Financhill
Buy
60

HALO Quote, Financials, Valuation and Earnings

Last price:
$53.88
Seasonality move :
1.46%
Day range:
$53.55 - $54.40
52-week range:
$42.01 - $70.51
Dividend yield:
0%
P/E ratio:
14.34x
P/S ratio:
6.40x
P/B ratio:
13.78x
Volume:
1.4M
Avg. volume:
2.9M
1-year change:
8.93%
Market cap:
$6.6B
Revenue:
$1B
EPS (TTM):
$3.76

Earnings Data

Next earnings date for HALO
Aug 06
2025
Most recent earnings per share
$0.93
Missed by $0.01
(May 6/2025)
Consensus Estimate
$0.94
(May 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HALO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/06/2025 Q2 $282.7M -- -- $1.20 --
05/06/2025 Q1 $230.2M $264.9M $0.93 $0.94 -$0.01
02/18/2025 Q4 $285.7M $298M $1.06 $1.16 -$0.10
10/31/2024 Q3 $252.2M $290.1M $1.05 $1.00 $0.05
08/06/2024 Q2 $204.9M $231.4M $0.72 $0.76 -$0.04
05/07/2024 Q1 $199.6M $195.9M $0.60 $0.70 -$0.10
02/20/2024 Q4 $231.1M $230M $0.65 $0.83 -$0.18
11/06/2023 Q3 -- -- $0.61 $0.71 -$0.10
08/08/2023 Q2 -- -- $0.56 $0.64 -$0.08
05/09/2023 Q1 -- -- $0.29 $0.48 -$0.19
02/21/2023 Q4 -- -- $0.42 $0.47 -$0.05
11/08/2022 Q3 -- -- $0.44 $0.51 -$0.07
08/09/2022 Q2 -- -- $0.16 -- --
05/10/2022 Q1 -- -- $0.43 -- --
02/22/2022 Q4 -- -- $0.46 -- --
11/02/2021 Q3 -- -- $1.48 -- --
08/09/2021 Q2 -- -- $0.62 -- --
05/10/2021 Q1 -- -- $0.19 -- --
02/23/2021 Q4 -- -- $0.50 -- --
11/02/2020 Q3 -- -- $0.25 -- --
08/10/2020 Q2 -- -- $0.19 -- --
05/11/2020 Q1 -- -- -$0.04 -- --
02/24/2020 Q4 -- -- -$0.24 -- --
11/12/2019 Q3 -- -- -$0.17 -- --
08/06/2019 Q2 -- -- -$0.10 -- --
05/07/2019 Q1 -- -- $0.01 -- --
02/21/2019 Q4 -- -- -$0.01 -- --
11/06/2018 Q3 -- -- -$0.19 -- --
08/07/2018 Q2 -- -- -$0.16 -- --
05/10/2018 Q1 -- -- -$0.19 -- --
02/20/2018 Q4 -- -- $0.85 -- --
11/07/2017 Q3 -- -- $0.02 -- --
08/08/2017 Q2 -- -- -$0.23 -- --
05/09/2017 Q1 -- -- -$0.26 -- --
02/28/2017 Q4 -- -- -$0.21 -- --
11/07/2016 Q3 -- -- -$0.23 -- --
08/09/2016 Q2 -- -- -$0.21 -- --
05/09/2016 Q1 -- -- -$0.16 -- --
02/29/2016 Q4 -- -- $0.03 -- --
11/09/2015 Q3 -- -- -$0.19 -- --
08/10/2015 Q2 -- -- $0.02 -- --

Halozyme Therapeutics Earnings Questions

  • How Much did Halozyme Therapeutics Generate in Revenue Last Quarter?

    Halozyme Therapeutics reported $264.9M worth of top line sales in its most recent quarter.

  • Did Halozyme Therapeutics Beat Earnings Last Quarter?

    Halozyme Therapeutics announced earnings per share of $0.93 which represents a miss of analyst forecast a $0.94 per share.

  • Is Halozyme Therapeutics Profitable?

    Halozyme Therapeutics reported $216.5M that represents $1.71 per share over the last quarter.

  • What is the Analyst Consensus for Halozyme Therapeutics EPS Next Year?

    Halozyme Therapeutics's earnings are forecast to grow from $3.43 per share to $4.13 per share next year representing an increase of 54.37%.

  • When is Halozyme Therapeutics's Earnings Date?

    Halozyme Therapeutics's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Is Target’s Dividend Worth Buying?
Is Target’s Dividend Worth Buying?

Retail giant Target (NYSE:TGT) has been through an extremely volatile…

Where Will AST SpaceMobile Be In 5 Years?
Where Will AST SpaceMobile Be In 5 Years?

Ever tried to send a text from the Nevada desert…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
37
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
49
RGC alert for Jun 17

Regencell Bioscience Holdings [RGC] is up 18.38% over the past day.

Buy
59
SYM alert for Jun 17

Symbotic [SYM] is down 1.73% over the past day.

Sell
43
TNXP alert for Jun 17

Tonix Pharmaceuticals Holding [TNXP] is down 2.16% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock